Ultrafiltration for Volume Control in Decompensated Heart Failure

Heart Failure Clinics

Volumn 4, Issue 4, 2008, Pages 519-534

  Haas, Garrie J ^a   Pestritto, Vincent M ^a   Abraham, William T ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; DOBUTAMINE; FUROSEMIDE; MILRINONE;

DECOMPENSATED HEART FAILURE; DRUG COST; DRUG SAFETY; HEART FAILURE; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; PROGNOSIS; REVIEW; ULTRAFILTRATION;

DIURETICS; EDEMA; HEART FAILURE; HUMANS; PROGNOSIS; TREATMENT FAILURE; ULTRAFILTRATION;

EID: 50049093481     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2008.03.004     Document Type: Review

References (68)

1. Starling R.C. Global pandemic of heart failure. In: Topol E.J. (Ed). Textbook of cardiovascular medicine. 3rd edition (2007), Lippincott, Williams & Wilkins, Philadelphia 1330-1338
2. Thom T., Haase N., Rosamond W., et al. Heart disease and stroke statistics-2006 update. A report from the American Heart Association statistics committee and the stroke statistics subcommittee. Circulation 113 (2006) e85-e151
3. Iyengar S., Haas G.J., and Young J.B. Acute heart failure. In: Topol E.J. (Ed). Textbook of cardiovascular medicine. 3rd edition (2007), Lippincott, Williams & Wilkins, Philadelphia 1352-1372
4. Fonarow G.C. Acute decompensated heart failure: challenges and opportunities. Rev Cardiovasc Med 8 Suppl 5 (2007) S3-S12
5. Fonarow G.C., Abraham W.T., Albert N.M., et al. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF). Arch Intern Med 167 (2007) 1493-1502
6. Fonarow G.C., Heywood J.T., Heidenreich P.A., et al. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002-2004: findings from acute decompensated heart failure national registry (ADHERE). Am Heart J 153 (2007) 1021-1028
7. Gheorghiade M., Abraham W.T., Albert N.M., et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 296 (2006) 2217-2226
8. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure). Circulation 112 (2005) 1825-1852
9. Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 12 (2006) 10-38
10. Kitzman D.W., Gardin J.M., Gottdiener J.S., et al. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol 87 (2001) 413-419
11. Fonarow G.C., and Adams K.F. for the ADHERE investigators. Risk stratification for in-hospital mortality in heart failure using classification and regression tree (CART) methodology: analysis of 33,046 patients in the ADHERE registry. JAMA 293 (2005) 572-580
12. Heywood J.T., and Khan T.A. The use of vasoactive therapy for acute decompensated heart failure: hemodynamic and renal considerations. Rev Cardiovasc Med 8 Suppl 5 (2007) 522-529
13. Iyengar S., and Abraham W.T. Diuretic resistance in heart failure. Curr Heart Fail Rep 3 (2006) 41-45
14. Schrier R.W. Role of diminished renal function in cardiovascular mortality. Marker or pathogenetic factor?. J Am Coll Cardiol 47 (2006) 1-8
15. Shlipak M.G., Chertow G.C., and Massie B.M. Beware the rising creatinine level. J Card Fail 9 (2003) 26-28
16. Hillege H.L., Girbes A.R.J., de Kam P.J., et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102 (2000) 203-210
17. Butler J., Forman D.E., Abraham W.T., et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 147 (2004) 331-338
18. Goldberg R.J., Ciampa J., Lessard D., et al. Long-term survival after heart failure. A contemporary population-based perspective. Arch Intern Med 167 (2007) 490-496
19. Sica D.A. Sodium and water retention in heart failure and diuretic therapy: basic mechanisms. Cleve Clin J Med 73 (2006) S2-S7
20. Krum H., and Cameron P. Diuretics in the treatment of heart failure: mainstay of therapy or potential hazard. J Card Fail 12 (2006) 333-335
21. Haas G.J., and Abraham W.T. Comprehensive pharmacologic management strategies in heart failure. In: Yu C.M., Hayes D.L., and Auricchio (Eds). Cardiac resynchronization therapy (2006), Blackwell, Oxford (UK) 13-31
22. Mebazaa A., Nieminen M.S., Packer M., et al. Levosimendan vs. dobutamine for patients with acute decompensated heart failure. The SURVIVE randomized trial. JAMA 297 (2007) 1883-1891
23. Schrier R.W., and Abraham W.T. Hormones and hemodynamics in heart failure. N Engl J Med 341 (1999) 577-585
24. Adams K.F., Fonarow G.C., Emerman C.L., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the acute decompensated heart failure national registry (ADHERE). Am Heart J 149 (2005) 209-216
25. Boyle A., Maurer M.S., and Sobotka P.A. Myocellular and interstitial edema and circulating volume expansion as a cause of morbidity and mortality in heart failure. J Card Fail 13 (2007) 133-136
26. Logeart D., Thabut G., Jourdain P., et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk for readmission after decompensated heart failure. J Am Coll Cardiol 43 (2004) 635-641
27. Stevenson L.W., Tillisch J.H., Hamilton M., et al. Importance of hemodynamic response to therapy in predicting survival with ejection fraction < 20% secondary to ischemic or non-ischemic dilated cardiomyopathy. Am J Cardiol 6 (1990) 1348-1354
28. Lucus C., Johnson W., Hamilton M.A., et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J 140 (2000) 840-847
29. Jessup M., Banner N., Brozena S., et al. Optimal pharmacologic and non-pharmacologic management of cardiac transplant candidates: approaches to be considered prior to transplant evaluation: International society for heart and lung transplantation guidelines for the care of transplant candidates-2006. J Heart Lung Transplant 25 (2006) 1003-1023
30. Brater D.C. Diuretic therapy. N Engl J Med 339 (1998) 387-395
31. Gottlieb S.S., Brater D.C., Thomas I., et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 105 (2002) 1348-1353
32. Weinfeld M.S., Chertow G.M., Stevenson L.W., et al. Am Heart J 138 (1999) 285-290
33. Neuberg G.W., Miller A.B., O'Connor C.M., et al. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J 144 (2002) 31-38
34. Ellison D.H. Diuretic therapy and resistance in congestive heart failure. Cardiology 96 (2001) 132-143
35. Hasselblad V., Stough W.G., Shah M.R., et al. Relationship between dose of loop diuretics and outcomes in a heart failure population: results of ESCAPE Trial. Eur J Heart Fail 9 (2007) 1064-1069
36. Domanski M., Tian X., Haigney M., et al. Diuretic use, progressive heart failure, and death in patients in the DIG study. J Card Fail 12 (2006) 327-332
37. Domanski M., Norman J., Pitt B., et al. Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 42 (2003) 705-708
38. Bayliss J., Norell M., Canepa-Anson R., et al. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 57 (1987) 17-22
39. McCurley J.M., Hanlon S.U., Wei S.K., et al. Furosemide and the progression of left ventricular dysfunction in experimental heart failure. J Am Coll Cardiol 44 (2004) 1301-1307
40. Bart B.A., and Goldsmith S.R. Aggravated renal dysfunction and the acute management of advanced chronic heart failure. Am Heart J 138 (1999) 200-202
41. Sica D. Renal function, diuretic action, and heart failure: a therapeutic conundrum. J Card Fail 13 (2007) 698-700
42. Tang W., and Francis G.S. The year in heart failure. J Am Coll Cardiol 48 (2006) 2575-2583
43. deGoma E.M., Vagelos R.H., Fowler M.B., et al. Emerging therapies for the management of decompensated heart failure. J Am Coll Cardiol 48 (2006) 2397-2409
44. Kolff W.J., and Leonards J.R. Reduction of otherwise intractable edema by dialysis or filtration. Cleve Clinic Q 21 (1954) 61-71
45. Ronco C., Ricci Z., Bellomo R., et al. Extracorporeal ultrafiltration for the treatment of overhydration and congestive heart failure. Cardiology 96 (2001) 155-168
46. Costanzo M.R. The role of ultrafiltration in the management of heart failure. Congest Heart Fail 14 (2008) 19-24
47. Silverstein M.E., Ford C.A., Lysaght M.J., et al. Treatment of severe fluid overload with ultrafiltration. N Engl J Med 291 (1974) 747-751
48. Lauer A., Saccaggi A., Ronco C., et al. Continuous arteriovenous hemofiltration in the critically ill patient. Clinical use and operational characteristics. Ann Intern Med 99 (1983) 455-460
49. Simpson I.A., Simpson K., Rae A.P., et al. Ultrafiltration in diuretic-resistant cardiac failure. Ren Fail 10 (1987) 115-119
50. Rimodini A., Cipolla C.M., Bella P.D., et al. Hemofiltration as a short-term treatment for refractory congestive heart failure. Am J Med 83 (1987) 43-48
51. Asada H., Bergstrom J., Furst P., et al. Treatment of diuretic resistant fluid retention with ultrafiltration. Acta Med Scand 204 (1978) 145-148
52. Cipolla C.M., Grazi S., Rimodini A., et al. Changes in circulating norepinephrine with hemofiltration in advanced congestive heart failure. Am J Cardiol 66 (1990) 987-994
53. Marenzi G.C., Grazi S., Giraldi F., et al. Interaction of humeral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration. Am J Med 94 (1993) 49-56
54. Agostoni P.G., Marenzi G.C., Pepi M., et al. Isolated ultrafiltration in moderate congestive heart failure. J Am Coll Cardiol 21 (1993) 424-431
55. Agostoni P.G., Marenzi G.C., Lauri G., et al. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. Am J Med 96 (1994) 191-199
56. Agostoni P.G., and Marenzi G.C. Sustained benefit from ultrafiltration in moderate congestive heart failure. Cardiology 96 (2001) 183-189
57. Marenzi G., Lauri G., Grazi M., et al. Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 38 (2001) 963-968
58. Ali S.S., Olinger C.C., Sobotka P.A., et al. Enhanced sodium extraction with ultrafiltration compared to intravenous diuretics. J Cardiac Fail (2006) (HFSA scientific session)
59. Blake P., Hasewaga Y., Khosla M.C., et al. Isolation of myocardial depressant factor(s) from ultrafiltrate of heart failure patients with acute renal failure. ASAIO J 42 (1996) M911-M915
60. Boyle A., and Sobotka P.A. Redefining the therapeutic objective in decompensated heart failure: hemoconcentration as a surrogate for plasma refill rate. J Card Fail 12 (2006) 247-249
61. Liang K.V., Hiniker A.R., Williams A.W., et al. Use of a novel ultrafiltration device as a treatment strategy for diuretic resistant, refractory heart failure: initial clinical experience in a single center. J Cardiac Fail 12 (2006) 707-714
62. Ronco C., Bellomo R., and Ricci Z. Hemodynamic response to fluid withdrawal in overhydrated patients treated with intermittent ultrafiltration and slow continuous ultrafiltration: role of blood volume monitoring. Cardiology 96 (2001) 196-201
63. Bourge R.C., Tallaj, and Ultrafiltration J.A. A new approach toward mechanical diuresis in heart failure. J Am Coll Cardiol 46 (2005) 2052-2053
64. Jaski B.E., Ha J., Denys B.G., et al. Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail 9 (2003) 227-231
65. Bart B.A., Boyle A., Bank A.J., et al. Ultrafiltration versus usual care for hospitalized patients with heart failure. The relief for acutely fluid overloaded patients with decompensated congestive heart failure (RAPID-CHF) trial. J Am Coll Cardiol 46 (2005) 2043-2046
66. Costanzo M.R., Saltzberg M., O'Sullivan J., et al. Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. J Am Coll Cardiol 46 (2005) 2047-2051
67. Costanzo M.R., Guglin M.E., Saltzberg M.T., et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49 (2007) 675-683
68. Elkayam U., Hatamizadeh P., and Janmohamed M. The challenge of correcting volume overload in hospitalized patients with decompensated heart failure. J Am Coll Cardiol 49 (2007) 684-686